Obi Greenman
Chief Executive Officer at CERUS CORPORATION
Net worth: 6 M $ as of 30/03/2024
Profile
William Mariner Greenman is currently the President, Chief Executive Officer & Director at Cerus Corp.
He previously served as an Independent Director at Aduro BioTech, Inc. and Chinook Therapeutics, Inc. He also held the position of Senior Vice President-Biotech Division at Baxter International, Inc. Mr. Greenman obtained his undergraduate degree from Stanford University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CERUS CORPORATION
1.75% | 13/03/2024 | 3,181,281 ( 1.75% ) | 6 M $ | 30/03/2024 |
Obi Greenman active positions
| Companies | Position | Start |
|---|---|---|
| CERUS CORPORATION | Chief Executive Officer | 20/04/2011 |
Former positions of Obi Greenman
| Companies | Position | End |
|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Director/Board Member | 10/08/2023 |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 31/12/1994 |
| CHINOOK THERAPEUTICS, INC. | Director/Board Member | - |
Training of Obi Greenman
| Stanford University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BAXTER INTERNATIONAL INC. | Health Technology |
| CERUS CORPORATION | Health Technology |
| Private companies | 2 |
|---|---|
Aduro BioTech, Inc.
 Aduro BioTech, Inc. Pharmaceuticals: MajorHealth Technology Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes. The company's platforms stimulate and/or regulate innate and adaptive immune responses, either as single agents or in combination with conventional therapies like chemotherapy and radiation as well as other novel immunotherapies. Aduro BioTech was founded in 2000 and is headquartered in Berkeley, CA. | Health Technology |
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Technology |
- Stock Market
- Insiders
- Obi Greenman
